← back to search

Maurizio Cutolo

University of Pisa · IT
Area of research
Pathology and Forensic Medicine · Rheumatology
Research interest
Research interests include Systemic Sclerosis and Related Diseases, Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, and Dermatologic Treatments and Research.
h-index
108
citations
55,325
works
1,144
NIH funding
primary concept
email

Recent publications

A matter arising: When should inflammatory and autoimmune rheumatic diseases be considered 'early'?
2026cited by 2position: contributordoi
Frailty phenotypes and determinants of glucocorticoid-related adverse events in polymyalgia rheumatica at 12 months: a real-life single-center investigation.
2026cited by 0position: contributordoi
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases.
2025cited by 16position: contributordoi
Cerebrovascular Involvement in Systemic Sclerosis.
2025cited by 4position: contributordoi
Soluble Co-Inhibitory Immune Checkpoint Molecules Are Increased in Patients With Polymyalgia Rheumatica Without Significant Correlations With Clinical Status: A Case-Control Study.
2025cited by 3position: contributordoi
Distribution of nailfold videocapillaroscopy parameters in systemic lupus erythematosus and their association with disease activity: an international blinded case-control analysis on behalf of the EULAR study group on microcirculation in rheumatic diseases.
2025cited by 3position: contributordoi
Nailfold videocapillaroscopy in juvenile dermatomyositis: detailed correlations between microvascular abnormalities with clinical and laboratory parameters from an observational retrospective single-center study.
2025cited by 2position: contributordoi
Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study.
2025cited by 1position: contributordoi
Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trial.
2025cited by 1position: contributordoi
Immune-modulatory effects of low oestrogen serum concentrations on the progression of ACPA-negative inflammatory arthritis in postmenopause.
2025cited by 1position: contributordoi
Vitamin D Status and Response to Supplementation as Predictive Factors for Early Remission in Polymyalgia Rheumatica: A Retrospective Longitudinal Investigation.
2025cited by 1position: contributordoi
Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation.
2025cited by 1position: contributordoi
Multicentre retrospective detection of nailfold videocapillaroscopy abnormalities in long covid patients.
2025cited by 1position: contributordoi
Differences in nailfold capillaroscopy findings between limited and diffuse cutaneous systemic sclerosis: a detailed analysis.
2025cited by 0position: contributordoi
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography.
2024cited by 23position: contributordoi
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Autoimmunity Reviews 2024cited by 21position: middledoi
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study
RMD Open 2024cited by 19position: middledoi
Vitamin D and Muscle Status in Inflammatory and Autoimmune Rheumatic Diseases: An Update.
2024cited by 15position: contributordoi
Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease.
2024cited by 11position: contributordoi
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study.
2024cited by 11position: contributordoi
Immunomodulatory Compounds from the Sea: From the Origins to a Modern Marine Pharmacopoeia.
2024cited by 5position: contributordoi
Microvascular status in juvenile Sjögren's disease: the first nailfold videocapillaroscopy investigation.
2024cited by 5position: contributordoi
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system's inhibitor denosumab vs. bisphosphonates.
2024cited by 5position: contributordoi
Geographical disparities in fibromyalgia severity: An Italian study
European Journal of Pain 2024cited by 5position: middledoi
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study.
2024cited by 4position: contributordoi
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
2024cited by 2position: contributordoi
Correction: Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease.
2024cited by 1position: contributordoi
An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study.
2024cited by 1position: contributordoi
Defining Interstitial Lung Disease Progression: It Is Time to (Get Our) Act Together.
2024cited by 0position: contributordoi
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
2023cited by 1,155position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 62 papers (2019–2026)Vanessa Smith · Gentofte Hospital26 papers (2018–2026)Carmen Pizzorni · Ospedale Policlinico San Martino25 papers (2020–2026)Emanuele Gotelli · Ospedale Policlinico San Martino24 papers (2020–2025) · 19 papers (2019–2026)Alberto Sulli · University of Genova10 papers (2022–2025)E. Hysa · University of Genoa9 papers (2022–2025)S. Paolino · Martin University8 papers (2020–2024)Carlo Alberto Scirè · University of Padua5 papers (2018–2020)Stefano Bombardieri · University of London5 papers (2013–2019)Francesca Ingegnoli · Center for Rheumatology5 papers (2020–2025)Maarten Boers · Phoenix Contact (United States)4 papers (2013–2023)Simona Rednic · Charité - Universitätsmedizin Berlin4 papers (2015–2022)J. W. J. Bijlsma · University of Groningen4 papers (2013–2019)Gerd R Burmester · Humboldt-Universität zu Berlin4 papers (2018–2022)Luc Mouthon · Ministere de l'Education Nationale4 papers (2018–2022)Matthias Schneider · Johannes Gutenberg University Mainz4 papers (2018–2019) · 4 papers (2013–2019)Zahir Amoura · Centre de Référence des Maladies Autoinflammatoires et des Amyloses3 papers (2019–2022)Marco Matucci‐Cerinic · ENT and Allergy3 papers (2015–2021)